Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MLC-activation by acute lymphatic leukemia blasts.

W Rella, H Winterleitner, W Knapp

    Blut
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oecologia·2017
    Same author

    Simultaneous Phenotypic and Genotypic Studies of Individual Mitotic Cells-Methods and Practical Applications.

    Leukemia & lymphoma·2016
    Same author

    Culture and animal experiments in tuberculosis diagnosis.

    Rontgenphotographie; medizinsche Photographie und medizinische Laboratoriumspraxis·2014
    Same author

    Dendritic Cell Generation from Highly Purified CD14+Monocytes.

    Methods in molecular medicine·2011
    Same author

    CD Antigens 1989: Summary of Nomenclature System for Human Leacocyte Surface Antigens.

    The American journal of pathology·2009
    Same author

    Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases.

    Leukemia·2006
    Same journal

    Clostridial septicaemia with intense hemolysis complicating septic abortion.

    Blut·1990
    Same journal

    Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).

    Blut·1990
    Same journal

    Flow cytometric analysis of tissue factor (TF) expression on stimulated monocytes--comparison to procoagulant activity of mononuclear blood cells.

    Blut·1990
    Same journal

    Coagulopathy after snake bite by Bothrops neuwiedi: case report and results of in vitro experiments.

    Blut·1990
    Same journal

    Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemia.

    Blut·1990
    Same journal

    Variations in erythropoiesis throughout a lifetime. Studies in a high-leukaemic mouse strain, the AKR/O strain, and a non-leukaemic strain, the WLO strain.

    Blut·1990
    See all related articles

    Leukemic blasts from acute lymphoblastic leukemia (ALL) show varied potential to activate mixed lymphocyte cultures (MLC). Some ALL blasts impair T-cell responses in whole blood, possibly due to reduced signaling factors.

    Area of Science:

    • Immunology
    • Hematology
    • Oncology

    Background:

    • Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy.
    • Mixed lymphocyte culture (MLC) is a key assay for assessing T-cell alloreactivity.
    • Understanding leukemic cell interactions with the immune system is crucial for ALL management.

    Purpose of the Study:

    • To investigate the mixed lymphocyte culture (MLC)-activating potential of acute lymphoblastic leukemia (ALL) blasts.
    • To characterize the heterogeneous immune-modulatory properties of ALL blasts in vitro.
    • To explore the implications for ALL classification and immunotherapeutic strategies.

    Main Methods:

    • Culturing mitomycin-treated ALL blasts with heparinized whole blood from healthy donors.
    • Measuring MLC activation, expressed as a percentage relative to X-irradiated lymphocyte stimulation.

    Related Experiment Videos

  • Comparing whole blood responses with those using isolated lymphocytes to assess blastogenic factor release.

    • Main Results:

    • Leukemic blasts exhibited a wide range of MLC-activating potential (2% to 245%).
    • Eleven of 25 ALL cases showed poor T-cell stimulation (2%-33%), while 12 showed normal (50%-120%) and 2 showed supranormal (>200%) responses.
    • Poor activation in whole blood was often overcome using isolated lymphocytes, suggesting impaired blastogenic factor release rather than active suppression.

    Conclusions:

    • ALL blasts display diverse immunomodulatory capacities, impacting T-cell activation.
    • Impaired blastogenic factor release may explain reduced T-cell responses in some ALL cases.
    • These findings highlight the importance of ALL blast immunophenotype for potential immunotherapies.